National Health Investors (NYSE:NHI) Price Target Raised to $76.00

National Health Investors (NYSE:NHI) had its price objective increased by Truist Financial from $70.00 to $76.00 in a research report report published on Wednesday,Benzinga reports. The brokerage currently has a hold rating on the real estate investment trust’s stock.

Separately, Wedbush restated an “outperform” rating and set a $88.00 price target on shares of National Health Investors in a research report on Monday, March 17th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $85.50.

National Health Investors Price Performance

Shares of NYSE:NHI opened at $73.47 on Wednesday. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The stock’s 50 day moving average is $70.37 and its 200-day moving average is $74.62. National Health Investors has a twelve month low of $57.80 and a twelve month high of $86.13. The firm has a market capitalization of $3.36 billion, a price-to-earnings ratio of 25.25, a PEG ratio of 4.42 and a beta of 1.08.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Tuesday, February 25th. The real estate investment trust reported $1.13 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.03. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business had revenue of $85.75 million during the quarter, compared to analyst estimates of $81.13 million. Sell-side analysts forecast that National Health Investors will post 4.41 EPS for the current fiscal year.

National Health Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 2nd. Stockholders of record on Monday, March 31st will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.90%. The ex-dividend date is Monday, March 31st. National Health Investors’s payout ratio is 115.38%.

Institutional Investors Weigh In On National Health Investors

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Norges Bank bought a new stake in National Health Investors during the fourth quarter valued at approximately $42,322,000. Millennium Management LLC boosted its position in National Health Investors by 1,967.0% during the 4th quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust’s stock valued at $33,843,000 after buying an additional 464,727 shares during the period. Balyasny Asset Management L.P. bought a new stake in shares of National Health Investors in the 4th quarter worth approximately $23,917,000. Marshall Wace LLP increased its position in shares of National Health Investors by 161.6% during the fourth quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust’s stock valued at $38,225,000 after buying an additional 340,712 shares during the period. Finally, Zimmer Partners LP purchased a new position in National Health Investors during the third quarter valued at $25,218,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.